Literature DB >> 19150316

Parenchymal extinction: coagulation and hepatic fibrogenesis.

Quentin M Anstee1, Mark Wright2, Robert Goldin3, Mark R Thursz4.   

Abstract

Observations that hepatic inflammation and cirrhosis are associated with the presence of thrombi within the hepatic microvasculature and fibrin-fibrinogen deposition have led to epidemiologic studies showing that carriage of the factor V Leiden mutation, protein C deficiency, and increased expression of factor VIII are associated with rapid progression to cirrhosis in a chronic hepatitis C virus. Additional data suggest that this process may extend more broadly to progression in many forms of chronic liver disease. This article discusses the evidence for a role for coagulation cascade activity in hepatic fibrogenesis and explores the proposed pathogenic mechanisms including the downstream events of thrombin activation. Interference with either the generation of thrombin or its downstream activity may reduce hepatic fibrosis. Also examined are the implications for future therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150316     DOI: 10.1016/j.cld.2008.09.013

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  22 in total

1.  Chronic liver injury drives non-traditional intrahepatic fibrin(ogen) crosslinking via tissue transglutaminase.

Authors:  L G Poole; A Pant; K S Baker; A K Kopec; H M Cline-Fedewa; S E Iismaa; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2018-12-10       Impact factor: 5.824

2.  Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.

Authors:  Carlos Noronha Ferreira; Daniela Reis; Helena Cortez-Pinto; Rui Tato Marinho; Afonso Gonçalves; Sónia Palma; Inês Leite; Tiago Rodrigues; Ana Júlia Pedro; Paula Alexandrino; Fátima Serejo; Margarida Sobral Dias; Paula Ferreira; Mariana Vasconcelos; Filipe Damião; Leonor Xavier Brito; Cilenia Baldaia; Narcisa Fatela; Fernando Ramalho; José Velosa
Journal:  Dig Dis Sci       Date:  2019-03-09       Impact factor: 3.199

Review 3.  Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients-pathogenesis, risk factors, and implications on management.

Authors:  Peter DeLeeuw; Uchenna Agbim
Journal:  Transl Gastroenterol Hepatol       Date:  2022-07-25

Review 4.  Pleiotropic effects of statins in the diseases of the liver.

Authors:  Martin Janicko; Sylvia Drazilova; Daniel Pella; Jan Fedacko; Peter Jarcuska
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

5.  Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.

Authors:  Prakash Ramachandran; Antonella Pellicoro; Madeleine A Vernon; Luke Boulter; Rebecca L Aucott; Aysha Ali; Stephen N Hartland; Victoria K Snowdon; Andrea Cappon; Timothy T Gordon-Walker; Mike J Williams; Donald R Dunbar; Jonathan R Manning; Nico van Rooijen; Jonathan A Fallowfield; Stuart J Forbes; John P Iredale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-24       Impact factor: 11.205

Review 6.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

7.  Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Authors:  Francesca Romana Ponziani; Valerio De Stefano; Antonio Gasbarrini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-30       Impact factor: 2.576

Review 8.  Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?

Authors:  Dafna J Groeneveld; Lauren G Poole; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2021-05-03       Impact factor: 16.036

Review 9.  The hemostatic and thrombotic complications of liver disease.

Authors:  Hannah Stowe McMurry; Janice Jou; Joseph Shatzel
Journal:  Eur J Haematol       Date:  2021-07-29       Impact factor: 2.997

Review 10.  The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.

Authors:  Keren Borensztajn; Jan H von der Thüsen; Maikel P Peppelenbosch; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2009-11-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.